← Back to Investors

Perceptive Advisors

Perceptive Advisors is one of the largest dedicated healthcare investment managers in the world. They invest across the full capital structure, from venture to public equities and credit, with deep expertise in biopharmaceuticals and a strong track record of backing successful therapeutics companies.

Location
New York, New York, USA
Founded
1999
AUM
$10B+
Investment Range
$25M - $200M+
Focus
biotech-focused
Fund Stages
series-a, series-b, series-c, growth

Investment Thesis

Perceptive Advisors invests in innovative healthcare companies across all stages and structures. Their multi-strategy approach allows them to provide flexible capital solutions, from early-stage venture investments through public market support, backed by deep scientific and commercial expertise.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Joseph Edelman - Founder & CEO
  • James Flynn, MD, PhD - Managing Partner
  • Adam Stone - Partner

Other Key Team Members

  • Large investment team with scientific and financial backgrounds
  • Global presence with expertise across therapeutic areas

Focus Areas

  • Biopharmaceuticals
  • Biotechnology
  • Medical devices
  • Healthcare services
  • Diagnostics
  • Life science tools
  • Healthcare technology

Notable Investments

  • One of the most active healthcare crossover investors
  • Major positions in leading biotech companies
  • Strong track record across therapeutic areas

Notable Exits

  • Numerous successful IPOs in biopharma
  • Multiple M&A exits
  • Leading healthcare hedge fund returns

Sources